FDA Will Review AstraZeneca Nasal Spray Flu Vaccine
The U.S. Food and Drug Administration has agreed to review a nasal spray flu vaccine from AstraZeneca in early 2024 that would be the first home-administered flu vaccine if it's approved,...To view the full article, register now.
Already a subscriber? Click here to view full article